MXRX — Med X Income Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual income statement for Med X, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 1.03 | 1.01 | 1.85 |
| Cost of Revenue | |||
| Gross Profit | 0.163 | 0.075 | 0.282 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 4.57 | 5.99 | 9.18 |
| Operating Profit | -3.53 | -4.98 | -7.32 |
| Total Net Non Operating Interest Income / Expense | |||
| Gain / Loss on Sale of Assets | |||
| Total Net Non Operating Interest Income / Expense | |||
| Net Income Before Taxes | -3.54 | -4.97 | -7.34 |
| Net Income After Taxes | -3.54 | -4.97 | -7.34 |
| Net Income Before Extraordinary Items | |||
| Net Income | -3.54 | -4.97 | -7.34 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -3.54 | -4.97 | -7.34 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.659 | -0.985 | -1.37 |